MYDRIACYL Side Effects

6814633-6 | Condition Aggravated, Stress, Vision Blurred
on Jun 17, 2010 Female patient from BRAZIL , 49 years of age, was diagnosed with optical coherence tomography and was treated with Mydriacyl (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, stress (What is stress?), vision blurred. Mydriacyl dosage: 1 Ftt 2x Ou Ophthalmic. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), CRESTOR (View Crestor Review and Crestor Label ), GENTEAL (HYPROMELLOSE) (View Genteal (hypromellose) Review and Genteal (hypromellose) Label ).

6699489-7 | Blood Pressure Systolic Increased, Circulatory Collapse, Hyperhidrosis, Loss Of Consciousness, Pallor
Patient was taking Mydriacyl (View Usage). Patient had the following side effects: blood pressure systolic increased, circulatory collapse, hyperhidrosis, loss of consciousness, pallor on Apr 15, 2010 from LATVIA Additional patient health information: Female patient , 55 years of age, was diagnosed with diagnostic procedure and. Mydriacyl dosage: 1 Gtt Ou. During the same period patient was treated with THYROZOL (THIAMAZOLE (View Thyrozol (thiamazole Review and Thyrozol (thiamazole Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), TORASEMID HEXAL PHARMA (TORASEMIDE) (View Torasemid Hexal Pharma (torasemide) Review and Torasemid Hexal Pharma (torasemide) Label ).

6687416-8 | Blood Pressure Immeasurable, Circulatory Collapse, Fatigue, Hyperhidrosis, Loss Of Consciousness, Pallor
Adverse event was reported on Apr 01, 2010 by a Female patient taking Mydriacyl (View Usage) (Dosage: Ophthalmic) . Location: LATVIA , 55 years of age, After Mydriacyl was administered, patient had the following side effects: blood pressure immeasurable, circulatory collapse, fatigue, hyperhidrosis, loss of consciousness, pallor. During the same period patient was treated with THYROZOL (THIAMAZOLE) (View Thyrozol (thiamazole) Review and Thyrozol (thiamazole) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), TORASEMID HEXAL PHARMA (TORASEMIDE) (View Torasemid Hexal Pharma (torasemide) Review and Torasemid Hexal Pharma (torasemide) Label ).

6582146-5 | Eye Irritation, Eye Pain, Headache
on Feb 12, 2010 Female patient from UNITED STATES , 60 years of age, weighting 190.0 lb, was diagnosed with glaucoma (What is glaucoma?), eye inflammation and was treated with Mydriacyl (View Usage). Patient experienced the following unwanted or unexpected effects: eye irritation, eye pain, headache (What is headache?). Mydriacyl dosage: 1 Drop Each Eye 1 Time Topical. During the same period patient was treated with NEVANAC (1 Drop Each Eye 3x Daily Topical) (View Nevanac Review and Nevanac Label ).


6406922-4 | Lack Of Spontaneous Speech, Transient Ischaemic Attack, Visual Impairment
on Oct 09, 2009 Female patient from UNITED STATES , 64 years of age, was diagnosed with ophthalmological examination and was treated with Mydriacyl (View Usage). Patient had the following side effects: lack of spontaneous speech, transient ischaemic attack, visual impairment. Mydriacyl dosage: (1 Gtt Ou 3x-one Time Use Ophthalmic). During the same period patient was treated with NEO SYNEPHRINOL (View Neo-synephrinol Review and Neo-synephrinol Label ). Patient was hospitalized.

6403462-3 | Hypersomnia, Loss Of Consciousness, Road Traffic Accident
Patient was taking Mydriacyl (View Usage). After Mydriacyl was administered, patient had the following side effects: hypersomnia, loss of consciousness, road traffic accident on Oct 15, 2009 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 140.0 lb, was diagnosed with ophthalmological examination and. Mydriacyl dosage: .

6379119-4 | Aphasia, Transient Ischaemic Attack
Adverse event was reported on Sep 08, 2009 by a Female patient taking Mydriacyl (View Usage) (Dosage: 1 Gtt Ou 3x-one Time Use Ophthalmic) was diagnosed with ophthalmological examination and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), transient ischaemic attack. Patient was hospitalized.

6121881-X | Visual Acuity Reduced
on Mar 03, 2009 Female patient from CANADA , 55 years of age, was diagnosed with fundoscopy and was treated with Mydriacyl (View Usage). Patient had the following side effects: visual acuity reduced. Mydriacyl dosage: 1 Gtt Ou Ophthalmic.

5492039-2 | Dizziness, Hyperhidrosis, Nausea, Paraesthesia
on Oct 18, 2007 Female patient from UNITED STATES , 37 years of age, was diagnosed with ophthalmological examination and was treated with Mydriacyl (View Usage). After Mydriacyl was administered, patient had the following side effects: dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?), paraesthesia. Mydriacyl dosage: One Drop To Each Eye One Time Ophthalmic.

5477674-X | Dizziness, Nausea
Patient was taking Mydriacyl (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?) on Oct 03, 2007 from UNITED STATES Additional patient health information: Female patient , 25 years of age, . Mydriacyl dosage: Intraocular;;0;0. During the same period patient was treated with PROPARACAINE HCL (Intraocular;;0;0) (View Proparacaine Hcl Review and Proparacaine Hcl Label ).

5368140-0 | Convulsion, Drooling, Epilepsy, Tremor
Adverse event was reported on Jun 05, 2007 by a Male patient taking Mydriacyl (View Usage) (Dosage: Ophthalmic) was diagnosed with ophthalmological examination and. Location: UNITED STATES , child 4 years of age, Patient had the following side effects: convulsion, drooling, epilepsy (What is epilepsy?), tremor. During the same period patient was treated with PROPARACAINE HYDROCHLORIDE SOLUTION (Ophthalmic) (View Proparacaine Hydrochloride Solution Review and Proparacaine Hydrochloride Solution Label ).

5266715-0 | Angle Closure Glaucoma, Iris Disorder
on Feb 26, 2007 Male patient from UNITED KINGDOM , 74 years of age, weighting 176.4 lb, was treated with Mydriacyl (View Usage). After Mydriacyl was administered, patient had the following side effects: angle closure glaucoma, iris disorder. Mydriacyl dosage: Eye Drops; Solution. During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ).